Information Journal Paper
APA:
Copy. (2018). UBE2C is a potential biomarker of intestinal-type gastric cancer with chromosomal instability. FRONTIERS IN PHARMACOLOGY, 9(-), 847-847. SID. https://sid.ir/paper/723557/en
Vancouver:
Copy. UBE2C is a potential biomarker of intestinal-type gastric cancer with chromosomal instability. FRONTIERS IN PHARMACOLOGY[Internet]. 2018;9(-):847-847. Available from: https://sid.ir/paper/723557/en
IEEE:
Copy, “UBE2C is a potential biomarker of intestinal-type gastric cancer with chromosomal instability,” FRONTIERS IN PHARMACOLOGY, vol. 9, no. -, pp. 847–847, 2018, [Online]. Available: https://sid.ir/paper/723557/en